Macquarie $1.33 Value Price, page-29

And how many quarters do you estimate that to be, Madame? Once recruitment for the heart trials slows, I believe their cash burn will drop dramatically. Whatever, concerns about their cash position have certainly been alleviated with the recent raising. And rather strange, don't you think, that Macquarie's new target has suddenly been slashed, when prior to the disastrous US IPO, their target was a tad higher? I'm curious to try and understand what has changed, apart from perception, in terms of the status of their 4 Phase 3 trials, the distinct possibility of their participation in the FDA voucher system discussed in previous posts etc etc. Without resorting to the hysterical outbursts from your favourite antagonist, the True Keeper of the Flame, (golly, I do so hope that's not an insult as it's not intended to be!) I remain a believer!